Literature DB >> 26061543

Once upon a time in dialysis: the last days of Kt/V?

Raymond Vanholder1, Griet Glorieux1, Sunny Eloot1.   

Abstract

After its proposal as a marker of dialysis adequacy in the eighties of last century, Kt/V(urea) helped to improve dialysis efficiency and to standardize the procedure. However, the concept was developed when dialysis was almost uniformly short and was applied thrice weekly with small pore cellulosic dialyzers. Since then dialysis evolved in the direction of many strategic alternatives, such as extended or daily dialysis, large pore high-flux dialysis, and convective strategies. Although still a useful baseline marker, Kt/V(urea) no longer properly covers up for most of these modifications so that urea kinetics are hardly if at all representative for those of other solutes with a deleterious effect on morbidity and mortality of uremic patients. This is corroborated in several clinical studies showing a dissociation between removal of urea and that of other uremic toxins. In addition, randomized controlled trials showed no benefit of increasing Kt/V(urea). Finally, this parameter also hardly is evocative for metabolic or intestinal generation of toxins, for their removal by residual renal function and for the complex interaction of dialysis length with removal pattern and patient outcomes. We conclude that apart from being a baseline parameter of dialysis adequacy, Kt/V(urea) insufficiently represents all novel strategic changes of modern dialysis. Kt/V(urea) is too simple a concept for the complexities of uremia and of today's dialysis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26061543     DOI: 10.1038/ki.2015.155

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  43 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes?

Authors:  Raymond Vanholder; Natalie Meert; Wim Van Biesen; Timothy Meyer; Thomas Hostetter; Annemieke Dhondt; Sunny Eloot
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

3.  Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins.

Authors:  Sunny Eloot; Eva Schepers; Daniela V Barreto; Fellype C Barreto; Sophie Liabeuf; Wim Van Biesen; Francis Verbeke; Griet Glorieux; Gabriel Choukroun; Ziad Massy; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

Review 4.  An update on uremic toxins.

Authors:  N Neirynck; R Vanholder; E Schepers; S Eloot; A Pletinck; G Glorieux
Journal:  Int Urol Nephrol       Date:  2012-08-15       Impact factor: 2.370

Review 5.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

6.  Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Authors:  Nosratola D Vaziri; Jun Yuan; Keith Norris
Journal:  Am J Nephrol       Date:  2012-12-19       Impact factor: 3.754

7.  Effect of membrane permeability on survival of hemodialysis patients.

Authors:  Francesco Locatelli; Alejandro Martin-Malo; Thierry Hannedouche; Alfredo Loureiro; Menelaos Papadimitriou; Volker Wizemann; Stefan H Jacobson; Stanislaw Czekalski; Claudio Ronco; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

8.  Kt/V underestimates the hemodialysis dose in women and small men.

Authors:  Elaine M Spalding; Shahid M Chandna; Andrew Davenport; Ken Farrington
Journal:  Kidney Int       Date:  2008-05-28       Impact factor: 10.612

9.  Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.

Authors:  Nhat M Pham; Natalie S Recht; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 8.237

10.  Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?

Authors:  Sunny Eloot; Wim Van Biesen; Griet Glorieux; Nathalie Neirynck; Annemieke Dhondt; Raymond Vanholder
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more
  20 in total

1.  A new technique for low-volume continuous sampling of spent dialysate: a validation study.

Authors:  Rafael Bueno Orcy; Maria Fernanda Antunes; Jean Pierre Oses; Maristela Böhlke
Journal:  J Artif Organs       Date:  2019-02-08       Impact factor: 1.731

2.  American Society of Nephrology Quiz and Questionnaire 2015: ESRD/RRT.

Authors:  Charmaine E Lok; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

3.  Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.

Authors:  Timothy W Meyer; Tammy L Sirich; Kara D Fong; Natalie S Plummer; Tariq Shafi; Seungyoung Hwang; Tanushree Banerjee; Yunnuo Zhu; Neil R Powe; Xin Hai; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

4.  HEMO Revisited: Why Kt/Vurea Only Tells Part of the Story.

Authors:  Björn Meijers; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2016-06-07       Impact factor: 10.121

Review 5.  Single needle hemodialysis: is the past the future?

Authors:  Raymond Vanholder
Journal:  J Nephrol       Date:  2019-09-19       Impact factor: 3.902

6.  Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes.

Authors:  Stephanie M Toth-Manikowski; Tammy L Sirich; Timothy W Meyer; Thomas H Hostetter; Seungyoung Hwang; Natalie S Plummer; Xin Hai; Josef Coresh; Neil R Powe; Tariq Shafi
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

7.  Training with an Electric Exercise Bike versus a Conventional Exercise Bike during Hemodialysis for Patients with End-stage Renal Disease: A Randomized Clinical Trial.

Authors:  Misa Miura; Ryo Yoshizawa; Shigeru Oowada; Aki Hirayama; Osamu Ito; Masahiro Kohzuki; Teruhiko Maeba
Journal:  Prog Rehabil Med       Date:  2017-06-15

Review 8.  The membrane perspective of uraemic toxins: which ones should, or can, be removed?

Authors:  Sudhir K Bowry; Peter Kotanko; Rainer Himmele; Xia Tao; Michael Anger
Journal:  Clin Kidney J       Date:  2021-12-27

Review 9.  Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine.

Authors:  Bernard Canaud; Stefano Stuard; Frank Laukhuf; Grace Yan; Maria Ines Gomez Canabal; Paik Seong Lim; Michael A Kraus
Journal:  Clin Kidney J       Date:  2021-12-27

10.  Monitoring dialysis adequacy: history and current practice.

Authors:  Linda Ding; James Johnston; Maury N Pinsk
Journal:  Pediatr Nephrol       Date:  2021-01-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.